ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/021/SRR33040221/SRR33040221_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/027/SRR33040227/SRR33040227_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/025/SRR33040225/SRR33040225_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/019/SRR33040219/SRR33040219_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/021/SRR33040221/SRR33040221_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/027/SRR33040227/SRR33040227_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/026/SRR33040226/SRR33040226_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/023/SRR33040223/SRR33040223_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/024/SRR33040224/SRR33040224_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/020/SRR33040220/SRR33040220_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/022/SRR33040222/SRR33040222_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/024/SRR33040224/SRR33040224_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/026/SRR33040226/SRR33040226_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/020/SRR33040220/SRR33040220_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/023/SRR33040223/SRR33040223_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/022/SRR33040222/SRR33040222_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/025/SRR33040225/SRR33040225_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR330/019/SRR33040219/SRR33040219_2.fastq.gzprimaryOK200GenomicsChongqing Medical Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA1248217xref:EuropePMC:PMC12212275We used SDCBP knockout A549 cells that recombinantly express wildtype, S6A and S6D SDCBP. We examined the associated transcriptome data and detected alterations in certain cancer-related signaling pathways.ENAfalseSequencing of A549 overexpressing SDCBP2025-04-122025-04-12PRJNA1248217